收藏切换
Advances in the study of peptide drugs in oral drug delivery system
收藏切换
PDF
Qi LI, Hong-da CHEN, Tian-hua ZHOU, Xiang-rui LIU*
Acta Pharmaceutica Sinica | 2022, 57(7) : 2012 - 2023
Less
收藏切换
Acta Pharmaceutica Sinica | 2022, 57(7): 2012-2023
Reviews
Advances in the study of peptide drugs in oral drug delivery system
Full
Qi LI, Hong-da CHEN, Tian-hua ZHOU, Xiang-rui LIU*
Affiliations
  • School of Basic Medical Sciences, Zhejiang University, Hangzhou 310058, China
Published: 2022-07-12 doi: 10.16438/j.0513-4870.2021-1491
Outline
收藏切换

Peptide drugs exhibit an irreplaceable role in clinics due to their high specificity, efficiency and low toxicity. At present, more than 80 peptide drugs have been approved for marketing with global sales exceeding $50 billion in 2019. However, with large molecular weights, high hydrophilicity and instability in digestive tract, oral peptide drugs encounter substantial physiological barriers leading to low oral bioavailability. Therefore, peptide drugs are mostly administered by parenteral routes. Although parenteral delivery of peptide drugs achieves high bioavailability, this is associated with inconvenience and discomfort, even causing severe side effects compared with the oral route possessing a high degree of patient compliance. Therefore, numerous studies concentrate on novel strategies to improve the oral bioavailability of peptide drugs. Some delivery technologies such as Eligen™ and Axcess™ have been successfully applied to the oral dosage form of therapeutic peptides and have accelerated relevant oral formulations for Food and Drug Administration (FDA) approval and clinical treatment. In this review, we focus on the oral peptide delivery, mainly summarizing the progress of recent strategies used to overcome oral barriers and the commercialization applications of related patents, which could facilitate the research and development (R & D) of clinical applications of oral delivery techniques for peptide drugs.

peptide drug  /  oral drug administration  /  gastrointestinal absorption  /  permeation enhancer  /  patent medicine  /  drug delivery system
Qi LI, Hong-da CHEN, Tian-hua ZHOU, Xiang-rui LIU. Advances in the study of peptide drugs in oral drug delivery system[J]. Acta Pharmaceutica Sinica, 2022 , 57 (7) : 2012 -2023 . DOI: 10.16438/j.0513-4870.2021-1491
Year 2022 volume 57 Issue 7
PDF
219
100
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2021-1491
  • Receive Date:2021-10-17
  • Online Date:2025-12-23
  • Published:2022-07-12
Article Data
Affiliations
History
  • Received:2021-10-17
  • Revised:2021-12-01
Funding
Affiliations
    School of Basic Medical Sciences, Zhejiang University, Hangzhou 310058, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2021-1491
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT